Showing results (181-190 of 229) with videos related to
Sort By:
Pageof 23
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 28, 2013
Designing clinical trials for dystoniaWendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.Annals of Clinical and Translational Neurology|April 15, 2020
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson diseaseDaniel Weintraub, Chelsea Caspell-Garcia, Tanya Simuni, et al.JAMA Neurology|December 14, 2020
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical TrialTanya Simuni, Brian Fiske, Kalpana Merchant, et al.Annals of Neurology|May 7, 2026
How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early-Stage Neuronal Alpha-Synuclein DiseaseTanya Simuni, Christopher S Coffey, Catherine M Kopil, et al.Acta Neuropathologica Communications|November 7, 2021
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's diseaseMarco J Russo, Christina D Orru, Luis Concha-Marambio, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's diseaseBrit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.Annals of Neurology|May 19, 2026
Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers InitiativePaulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.Journal of Parkinson'S Disease|July 17, 2023
Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease ProgressionMichael C Brumm, Andrew Siderowf, Tanya Simuni, et al.JAMA Neurology|August 28, 2013
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson diseaseJu-Hee Kang, David J Irwin, Alice S Chen-Plotkin, et al.Annals of Neurology|June 17, 2020
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's DiseaseDavid J Irwin, Janel Fedler, Christopher S Coffey, et al.Pageof 23